Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: humanised anti glycoprotein Ib murine monoclonal antibodies - Oxurion

Drug Profile

Research programme: humanised anti glycoprotein Ib murine monoclonal antibodies - Oxurion

Alternative Names: Fab 6B4; Humanised anti glycoprotein Ib murine monoclonal antibodies research programme - Oxurion; Humanised murine anti-GP Ib-Mab 6B4 - Oxurion; TGX 6B4

Latest Information Update: 11 Sep 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator University of Leuven
  • Class Monoclonal antibodies
  • Mechanism of Action GPIb receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Arterial thrombosis

Most Recent Events

  • 10 Sep 2018 Thrombogenics is now called Oxurion
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Arterial-thrombosis in Europe (Parenteral, Injection)
  • 04 Jan 2007 Preclinical development is ongoing
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top